Daré Bioscience Announces Publication in Menopause: The Journal of The North American Menopause Society of Data from Phase 1 Trial of DARE-HRT1 that Support the Potential of DARE-HRT1 as an Effective Hormone Therapy for both Vasomotor and Vaginal Symptoms

January 26, 2023

https://www.globenewswire.com/news-release/2023/01/26/2596004/30757/en/Dar%C3%A9-Bioscience-Announces-Publication-in-Menopause-The-Journal-of-The-North-American-Menopause-Society-of-Data-from-Phase-1-Trial-of-DARE-HRT1-that-Support-the-Potential-of-DARE-HR.html



NASDAQ and NYSE quotes and data are delayed 15 minutes unless indicated otherwise. Market data and exchange information are provided for informational purposes only and is not intended for trading purposes. Neither 24/7 Market News Editors, 247 Market News, or data and content providers shall be liable for any errors or omissions, delays, misquotes or other market information relayed in any press materials. You should Use Realtime data to conduct due diligence before investing or trading, and trading in any stock is risky you could lose all your money.